These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 33901620

  • 1. Strategic feeding of NS0 and CHO cell cultures to control glycan profiles and immunogenic epitopes of monoclonal antibodies.
    Villacrés C, Tayi VS, Butler M.
    J Biotechnol; 2021 Jun 10; 333():49-62. PubMed ID: 33901620
    [Abstract] [Full Text] [Related]

  • 2. Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells.
    Baker KN, Rendall MH, Hills AE, Hoare M, Freedman RB, James DC.
    Biotechnol Bioeng; 2001 May 05; 73(3):188-202. PubMed ID: 11257601
    [Abstract] [Full Text] [Related]

  • 3. Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells.
    Hills AE, Patel A, Boyd P, James DC.
    Biotechnol Bioeng; 2001 Oct 20; 75(2):239-51. PubMed ID: 11536148
    [Abstract] [Full Text] [Related]

  • 4. The availability of glucose to CHO cells affects the intracellular lipid-linked oligosaccharide distribution, site occupancy and the N-glycosylation profile of a monoclonal antibody.
    Liu B, Spearman M, Doering J, Lattová E, Perreault H, Butler M.
    J Biotechnol; 2014 Jan 20; 170():17-27. PubMed ID: 24286971
    [Abstract] [Full Text] [Related]

  • 5. The role of protein hydrolysates in prolonging viability and enhancing antibody production of CHO cells.
    Obaidi I, Mota LM, Quigley A, Butler M.
    Appl Microbiol Biotechnol; 2021 Apr 20; 105(8):3115-3129. PubMed ID: 33796891
    [Abstract] [Full Text] [Related]

  • 6. An integrated modular framework for modeling the effect of ammonium on the sialylation process of monoclonal antibodies produced by CHO cells.
    Savizi ISP, Motamedian E, E Lewis N, Jimenez Del Val I, Shojaosadati SA.
    Biotechnol J; 2021 Aug 20; 16(8):e2100019. PubMed ID: 34021707
    [Abstract] [Full Text] [Related]

  • 7. Production of α2,6-sialylated IgG1 in CHO cells.
    Raymond C, Robotham A, Spearman M, Butler M, Kelly J, Durocher Y.
    MAbs; 2015 Aug 20; 7(3):571-83. PubMed ID: 25875452
    [Abstract] [Full Text] [Related]

  • 8. Engineering nucleotide sugar synthesis pathways for independent and simultaneous modulation of N-glycan galactosylation and fucosylation in CHO cells.
    Prabhu A, Shanmugam D, Gadgil M.
    Metab Eng; 2022 Nov 20; 74():61-71. PubMed ID: 36152932
    [Abstract] [Full Text] [Related]

  • 9. Understanding the effect of increased cell specific productivity on galactosylation of monoclonal antibodies produced using Chinese hamster ovary cells.
    Madabhushi SR, Podtelezhnikov AA, Murgolo N, Xu S, Lin H.
    J Biotechnol; 2021 Mar 10; 329():92-103. PubMed ID: 33549674
    [Abstract] [Full Text] [Related]

  • 10. Effects of nutrient levels and average culture pH on the glycosylation pattern of camelid-humanized monoclonal antibody.
    Aghamohseni H, Ohadi K, Spearman M, Krahn N, Moo-Young M, Scharer JM, Butler M, Budman HM.
    J Biotechnol; 2014 Sep 30; 186():98-109. PubMed ID: 25014402
    [Abstract] [Full Text] [Related]

  • 11. Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation.
    Ghaderi D, Zhang M, Hurtado-Ziola N, Varki A.
    Biotechnol Genet Eng Rev; 2012 Sep 30; 28():147-75. PubMed ID: 22616486
    [Abstract] [Full Text] [Related]

  • 12. Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins.
    Liu L.
    J Pharm Sci; 2015 Jun 30; 104(6):1866-1884. PubMed ID: 25872915
    [Abstract] [Full Text] [Related]

  • 13. An investigation of intracellular glycosylation activities in CHO cells: effects of nucleotide sugar precursor feeding.
    Wong NS, Wati L, Nissom PM, Feng HT, Lee MM, Yap MG.
    Biotechnol Bioeng; 2010 Oct 01; 107(2):321-36. PubMed ID: 20506284
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Transient CHO expression platform for robust antibody production and its enhanced N-glycan sialylation on therapeutic glycoproteins.
    Zhong X, Ma W, Meade CL, Tam AS, Llewellyn E, Cornell R, Cote K, Scarcelli JJ, Marshall JK, Tzvetkova B, Figueroa B, DiNino D, Sievers A, Lee C, Guo J, Mahan E, Francis C, Lam K, D'Antona AM, Zollner R, Zhu HL, Kriz R, Somers W, Lin L.
    Biotechnol Prog; 2019 Jan 01; 35(1):e2724. PubMed ID: 30299005
    [Abstract] [Full Text] [Related]

  • 18. CHO cell line specific prediction and control of recombinant monoclonal antibody N-glycosylation.
    Grainger RK, James DC.
    Biotechnol Bioeng; 2013 Nov 01; 110(11):2970-83. PubMed ID: 23737295
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.